A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

EudraCT number: 2008-004672-50


Study sites

  • UZ Leuven
  • St Elisabeth Namur
  • CHU Liège
  • CHA Libramont
  • AZ Groeninge Kortrijk
  • AZ Damiaan Oostende
  • AZ Sint-Lucas Gent
  • Imeldaziekenhuis Bonheiden
  • AZ St-Maarten Duffel

Professional Area